Volume: 31 Issue: 5

1. Role of chronic inflammation in obesity-related glomerulopathy Page:395—397
2. Research progress of galactose - deficient IgA1 antibodies in diagnosis and treatment of IgA nephropathy Page:392—394
3. Comparative study on emergency treatment and selective closed reduction and percutaneous pin fixation for hu-meral supracondylar fracture of Gartland typeⅡand typeⅢin children Page:384—387
4. Long non-coding RNA expression in neonatal rat brain tissue after hypoxic-ischemic injury Page:376—379
5. Clinical features and gene mutations analysis in 62 children with early - onset epileptic encephalopathy of un-known causes Page:371—375
6. Effect of erythropoietin on the expression and function of renal aquaporin - 2 after release of bilateral ureter obstruction in young rats Page:367—370
7. The clinical manifestations of children with endocapillary proliferative glomerulonephritis with isolated C3 deposition Page:363—366
8. Treatment of idiopathic membranous nephropathy in 35 children Page:341—344
9. Diagnosis and management of complications in nephrotic syndrome Page:333—336
10. Progress of diagnosis and treatment of fetal and newborn lower urinary tract obstruction Page:398—400
11. Screening and expression analysis of the specific tissue and serum microRNA profile in Hirschsprung disease Page:380—383
12. Step sequential therapy for treating children with post - renal acute renal failure induced by Ceftriaxone Page:359—362
13. Introduction of European Association of Urology/European Society for Paediatric Urology guidelines on urina-ry tract infection in children Page:337—340
14. Protective mechanism of ischemic preconditioning on apoptosis induced by kidney ischemia - reperfusion Page:354—358
15. Effect of Azithromycin on the level of interleukin - 23,interleukin - 17 in serum of rats with Adriamycin -induced nephrosis Page:349—353
16. Expression and significance of podocyte molecules mRNA in Doxorubicin-induced nephrotic rats Page:345—348
17. Common respiratory pathogen infection and kidney damage in children Page:329—333
18. Treatment of refractory nephrotic syndrome - novel medications and old newly used medications based on the mechanisms of proteinuria Page:324—328
19. Autosomal dominant polycystic kidney disease in children's early identification and outcome Page:321—324